13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001591986-23-000005
Total Value
$266.2M
Positions
13
Other Managers
0
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 1,103,515 | $44.8M | 16.81% |
| 2 | S&P BIOTECH ETF TR | 78464A870 | 500,000 | $41.5M | 15.59% |
| 3 | BLUEPRINT MEDICINES CORP | 09627Y109 | 581,768 | $25.5M | 9.57% |
| 4 | ARVINAS INC | ARVN | 673,941 | $23.1M | 8.66% |
| 5 | MERUS N V | N5749R100 | 1,432,109 | $22.2M | 8.32% |
| 6 | REGENXBIO INC | RGNX | 897,684 | $20.4M | 7.65% |
| 7 | SILENCE THERAPEUTICS PLC | SLNCF | 1,284,133 | $19.6M | 7.36% |
| 8 | KYMERA THERAPEUTICS INC | KYMR | 629,411 | $15.7M | 5.90% |
| 9 | AMRYT PHARMA PLC | 03217L106 | 2,098,993 | $15.3M | 5.76% |
| 10 | UNIQURE NV | QURE | 624,854 | $14.2M | 5.32% |
| 11 | GENMAB A/S | GNMSF | 242,848 | $10.3M | 3.87% |
| 12 | ARGENX SE | ARGX | 24,000 | $9.1M | 3.42% |
| 13 | PIERIS PHARMACEUTICALS INC | 720795103 | 4,552,876 | $4.7M | 1.78% |